The Europe acute lung injury market is expected to grow from US$ 156.55 million in 2021 to US$ 211.12 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.
The UK, Germany, France, Italy, and Spain are major economies in Europe. Growing prevalence of respiratory diseases is expected to fuel the market growth. The high prevalence of respiratory conditions is associated with the decrease in the size of the upper airway lumen in the aging population. Lung disorders are among the most common medical conditions across the region. People suffer from various sorts of respiratory diseases. Smoking, infections, and genetic factors are among the common factors responsible for respiratory disorders. Medical conditions such as COPD, asthma, chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens. In addition, the World Health Organization (WHO) states that millions of people die from lung cancer every year, making it the most common lethal infectious disease. In addition, 91% of the population lives in cities and places where the air quality is not optimum, as recommended by the WHO. Patients suffering from these respiratory disorders commonly experience difficulty in breathing. The respiratory failure associated with acute lung injury, or the acute respiratory distress syndrome (ARDS) is one of the most critical contributors to postoperative mortality. Moreover, state, and local health departments, and other clinical and public health associates continue to monitor smoking e-cigarette or vaping product use associated lung injury (EVALI). Thus, all the above-mentioned factors are expected to result in the growth of the Europe acute lung injury market during the forecast period.In case of COVID-19, Spain, Italy, Germany, France, and the UK are among the most affected European countries. As per the Worldometer, as of September 16, 2021, Spain, UK, Italy, Germany, and France recorded 4,922,249; 7,312,683; 4,618,040; 4,117,263; and 6,926,604, respectively, COVID-19 cases, and the deaths toll is also high in these countries. In addition, Novel coronavirus-associated disease (COVID-19) was first detected in Spain on 31 January 2020, with more than 204 178 cases subsequently identified in 3 months.1 Severe COVID-19 is associated with high circulating levels of inflammatory cytokines akin to a cytokine release syndrome that frequently results in respiratory failure. To date, scant histopathological information of infected patients is available. Few descriptions of histopathological findings have mainly reported pneumonitis and diffuse alveolar damage (DAD).2–5 To advance in the knowledge of COVID-19-associated tissue damage is important to understand the mechanisms of damage caused by SARS-COV-2.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe acute lung injury market. The Europe acute lung injury market is expected to grow at a good CAGR during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Acute Lung Injury Market Segmentation
Europe Acute Lung Injury Market – By Therapy
Europe Acute Lung Injury Market – By Therapy
- Mechanical Ventilation
- Fluid Management
- Pharmacotherapy
- Adjunctive Procedures
Europe Acute Lung Injury Market – By End User
- Hospitals
- Ambulatory Surgery Centers
- Others
Europe Acute Lung Injury Market, by Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Europe Acute Lung Injury Market - Companies Mentioned
- Apeiron Biologics AG
- APEPTICO Forschung und Entwicklung GmbH
- GlaxoSmithKline Plc
- Histocell
- Stemedica Cell Technologies, Inc
- Windtree Therapeutics, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Acute Lung Injury Market – By Therapy
1.3.2 Europe Acute Lung Injury Market – By End User
1.3.3 Europe Acute Lung Injury Market– By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Acute Lung Injury Market– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Acute Lung Injury Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Respiratory Diseases
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Overpriced Therapies
5.3 Market Opportunities
5.3.1 Surging Technological Advancements by Market Players
5.4 Future Trends
5.4.1 Escalating Pipeline Drugs
5.5 Impact Analysis
6. Acute Lung Injury Market– Europe Analysis
6.1 Europe Acute Lung Injury Market Revenue Forecast and Analysis
7. Europe Acute Lung Injury Market Analysis – By Therapy
7.1 Overview
7.2 Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)
7.3 Mechanical Ventilation
7.3.1 Overview
7.3.2 Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Fluid Management
7.4.1 Overview
7.4.2 Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Pharmacotherapy
7.5.1 Overview
7.5.2 Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Adjunctive Procedures
7.6.1 Overview
7.6.2 Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Acute Lung Injury Market Analysis – By End User
8.1 Overview
8.2 Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Ambulatory Surgery Centers
8.4.1 Overview
8.4.2 Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Acute Lung Injury Market – Country Analysis
9.1 Europe: Acute Lung Injury Market
9.1.1 Overview
9.1.2 Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)
9.1.2.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 Germany: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.1.3 Germany: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
9.1.2.2 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 France: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.2.3 France: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
9.1.2.3 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 UK: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.3.3 UK: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
9.1.2.4 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 Italy: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.4.3 Italy: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
9.1.2.5 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.1 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.2 Spain: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.5.3 Spain: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
9.1.2.6 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.1 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.2 Rest of Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)
9.1.2.6.3 Rest of Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Acute Lung Injury Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 GlaxoSmithKline Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stemedica Cell Technologies, Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Histocell
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 APEPTICO Forschung und Entwicklung GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Windtree Therapeutics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Apeiron Biologics AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. France: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 5. France: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Italy: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 9. Italy: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Spain: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 11. Spain: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Acute Lung Injury Market Segmentation
Figure 2. Europe Acute Lung Injury Market Segmentation, By Country
Figure 3. Europe Acute Lung Injury Market Overview
Figure 4. Mechanical Ventilation Segment Held the Largest Share of the Market in 2021
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Acute Lung Injury Market Impact Analysis of Driver and Restraints
Figure 8. Europe Acute Lung Injury Market– Revenue Forecast and Analysis
Figure 9. Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)
Figure 10. Europe Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)
Figure 15. Europe Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)
Figure 19. Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 20. Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in European Country Markets
- Apeiron Biologics AG
- APEPTICO Forschung und Entwicklung GmbH
- GlaxoSmithKline Plc
- Histocell
- Stemedica Cell Technologies, Inc
- Windtree Therapeutics, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Acute Lung Injury Market
Nov 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)